Junlin Yi Selected Research

Junlin Yi Research Topics

15	Neoplasms (Cancer) 02/2024 - 03/2005
12	Nasopharyngeal Carcinoma 11/2023 - 02/2014
7	Carcinoma (Carcinomatosis) 09/2023 - 01/2019
7	Neoplasm Metastasis (Metastasis) 08/2023 - 12/2014
5	Squamous Cell Carcinoma of Head and Neck 10/2022 - 07/2017
4	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 01/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 01/2020
3	Brain Neoplasms (Brain Tumor) 01/2021 - 12/2018
2	Glioma (Gliomas) 01/2022 - 12/2018
2	Margins of Excision 09/2020 - 11/2017
2	Hypoxia (Hypoxemia) 10/2009 - 05/2005
1	Adenocarcinoma 02/2024
1	Rare Diseases (Rare Disease) 12/2022
1	Hypopharyngeal Neoplasms 11/2022
1	Constipation 10/2022
1	Nausea 10/2022
1	Vomiting 10/2022
1	Hiccup (Hiccups) 10/2022
1	Prostatic Neoplasms (Prostate Cancer) 08/2022
1	Headache (Headaches) 01/2022
1	Necrosis 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2020
1	Disease Progression 01/2020
1	Pathologic Complete Response 01/2020
1	Papillary Carcinoma 10/2015
1	Residual Neoplasm 10/2015
1	Papillary Thyroid Cancer 10/2015
1	Deglutition Disorders (Dysphagia) 07/2015
1	Hypothyroidism 07/2015
1	Esophageal Squamous Cell Carcinoma 07/2015
1	Esophageal Neoplasms (Esophageal Cancer) 02/2015
1	Adenocarcinoma of Lung 10/2009
1	Medulloblastoma 03/2005

2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2023 - 12/2022
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 07/2017
1	nimotuzumabIBA 02/2024
1	4-nitrophenyl beta-cellobiosideIBA 12/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022
1	Capecitabine (Xeloda)FDA Link 10/2022
1	Aprepitant (Emend)FDA Link 10/2022
1	Ondansetron (Zofran)FDA LinkGeneric 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	AntiemeticsIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CytokinesIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Alprostadil (Muse)FDA LinkGeneric 12/2018
1	Therapeutic UsesIBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2015
1	Bevacizumab (Avastin)FDA Link 10/2009
1	Thymidine KinaseIBA 05/2005
1	Transcription Factors (Transcription Factor)IBA 05/2005
1	LuciferasesIBA 05/2005

34	Radiotherapy 02/2024 - 03/2005
12	Chemoradiotherapy 02/2024 - 02/2014
11	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2024 - 02/2014
5	Drug Therapy (Chemotherapy) 08/2023 - 01/2020
3	Induction Chemotherapy 11/2023 - 11/2022
3	Therapeutics 09/2023 - 01/2018
1	Re-Irradiation 11/2023
1	Immunotherapy 12/2022
1	Adjuvant Chemotherapy 10/2022
1	Adrenalectomy 01/2020
1	Laryngectomy 01/2020
1	Neck Dissection (Radical Neck Dissection) 01/2020
1	Adjuvant Radiotherapy 11/2017